BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25407700)

  • 1. Primary bone marrow lymphoma is a rare neoplasm with poor outcome: case series from single tertiary care centre and review of literature.
    Bhagat P; Sachdeva MU; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Law A; Malhotra P
    Hematol Oncol; 2016 Mar; 34(1):42-8. PubMed ID: 25407700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report Diffuse large B-cell lymphoma in the primary bone marrow.
    Hu Y; Chen SL; Huang ZX; Gao W; An N
    Genet Mol Res; 2015 Jun; 14(2):6247-50. PubMed ID: 26125825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary bone marrow B-cell non-Hodgkin's lymphoma successfully treated with R-CHOP.
    Qian L; Zhang Z; Shen J; Liu Y
    West Indian Med J; 2013 Jan; 62(1):89-91. PubMed ID: 24171336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary bone marrow diffuse large B cell lymphoma: a case series and review.
    Chang H; Hung YS; Lin TL; Wang PN; Kuo MC; Tang TC; Wu JH; Dunn P; Shih LY
    Ann Hematol; 2011 Jul; 90(7):791-6. PubMed ID: 21181164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid bone marrow dissemination after surgery in localized gastric diffuse large B-cell lymphoma: a case report.
    Isoda A; Hatsumi N; Ogawa Y; Matsumoto M; Sawamura M
    Int J Hematol; 2006 Dec; 84(5):471-2. PubMed ID: 17189234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
    Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse systemic large B-cell lymphoma with secondary skin involvement.
    Lloret-Ruiz C; Molés-Poveda P; Barrado-Solís N; Gimeno-Carpio E
    Actas Dermosifiliogr; 2015 Oct; 106(8):685-7. PubMed ID: 26092177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary lymphoma of the kidney. Report of a case and update of the literature.
    Porcaro AB; D'Amico A; Novella G; Curti P; Ficarra V; Antoniolli SZ; Martignoni G; Matteo B; Malossini G
    Arch Ital Urol Androl; 2002 Mar; 74(1):44-7. PubMed ID: 12053451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas.
    Kim JS; Gang GW; Lee SR; Sung HJ; Park Y; Kim DS; Choi CW; Kim BS
    Jpn J Clin Oncol; 2015 Oct; 45(10):914-20. PubMed ID: 26185139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.
    Hao X; Wei X; Huang F; Wei Y; Zeng H; Xu L; Zhou Q; Feng R
    PLoS One; 2015; 10(5):e0126615. PubMed ID: 25974110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
    Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review.
    Cao C; Liu T; Zhu H; Wang L; Kai S; Xiang B
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e145-50. PubMed ID: 25225082
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases.
    Oprea C; Cainap C; Azoulay R; Assaf E; Jabbour E; Koscielny S; Lapusan S; Vanel D; Bosq J; Ribrag V
    Br J Haematol; 2005 Nov; 131(4):468-71. PubMed ID: 16281936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse Large B Cell Lymphoma in a Male Breast - A Rare Case Report.
    Corobea AB; Dumitru A; Sajin M; Poenaru R; Puşcaşu A; Chirita D; Evsei A
    Chirurgia (Bucur); 2017; 112(4):477-481. PubMed ID: 28862126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.